Literature DB >> 3049115

Identification of a malignant cell associated antigen recognized by a human monoclonal antibody.

Y Aotsuka1, H Hagiwara.   

Abstract

A human X human hybridoma, CLNH11, derived from a lymphocyte of a patient with cervical carcinoma, produces a human monoclonal antibody of gamma 1 and kappa isotypes (CLN-IgG). Immunoperoxidase staining showed that CLN-IgG reacted with frozen tissue sections of human malignant tumors (cervical carcinoma, gall bladder carcinoma, glioblastoma), but not with their normal counterparts. Enzyme-linked immunosorbant assay also demonstrated that CLN-IgG reacted with various human tumor cell lines, but not with non-tumorigenic cells such as some fibroblasts, peripheral blood lymphocytes and red blood cells. Indirect and direct immunofluorescence staining indicated that the tumor antigens recognized by CLN-IgG were located in restricted areas close to the cell surface and exposed on the outer surface of the cell membrane. A protein antigen of Mr 226,000 was purified to homogeneity by affinity chromatography with CLN-IgG from the plasma membrane fraction of A549 lung tumor cell line. The antigen consisted of alpha (Mr 60,000) and beta subunit (Mr 53,000) which were linked by disulfide bond(s) (TA60K/53K). The TA60K/53k antigens were expressed commonly in other tumor cell lines originated from histologically different tissues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3049115     DOI: 10.1016/0277-5379(88)90191-5

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  2 in total

1.  Cell surface detection of vimentin, ACE2 and SARS-CoV-2 Spike proteins reveals selective colocalization at primary cilia.

Authors:  Vasiliki Lalioti; Silvia González-Sanz; Irene Lois-Bermejo; Patricia González-Jiménez; Álvaro Viedma-Poyatos; Andrea Merino; María A Pajares; Dolores Pérez-Sala
Journal:  Sci Rep       Date:  2022-04-29       Impact factor: 4.996

2.  Two Domains of Vimentin Are Expressed on the Surface of Lymph Node, Bone and Brain Metastatic Prostate Cancer Lines along with the Putative Stem Cell Marker Proteins CD44 and CD133.

Authors:  Nicole F Steinmetz; Jochen Maurer; Huiming Sheng; Armand Bensussan; Igor Maricic; Vipin Kumar; Todd A Braciak
Journal:  Cancers (Basel)       Date:  2011-07-13       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.